ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Agomab Therapeutics NV clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 8 studies whose lead sponsor is Agomab Therapeutics NV or one of 2 companies grouped under it. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 29, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Agomab Therapeutics NV with AbbVie and Sino Biopharmaceutical →

Pipeline: 2 programs

Each counted once: 2 with a study Agomab Therapeutics NV leads registered in the last two years.

  • Phase 2

The 2 programs — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Agomab Therapeutics NV’s own registered studies; Agomab Therapeutics NV’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Agomab Therapeutics NV’s studies test, most open studies first — 1 drug with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

All 8 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now338%Recruiting 2 · Not yet recruiting 1
  • Completed563%

Phase

  • Phase 15
  • Phase 23

Where

  • Belgium3
  • United Kingdom3
  • United States2
  • Denmark1
  • Germany1
  • Canada1

Over the years

  1. 323
  2. 24
  3. 25
  4. 326

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Agomab Therapeutics NV.

  • Agomab Spain S.L.U.
    Acquired — became part of Agomab Therapeutics NV, Dec 14, 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Agomab Spain S.L.
    Acquired — became part of Agomab Therapeutics NV, Dec 14, 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →

Studies

Recruiting first, then most recently updated. Showing 8 of 8.